Efficacy of adjunctive oral Janus kinase inhibitors in hospitalized patients with extensive or difficult-to-control drug eruptions: a retrospective observational case series. [PDF]
Zhu Y +10 more
europepmc +1 more source
Second-Window Indocyanine Green fluorescence imaging differentiates inflammation from necrotic tissue in early burn wounds. [PDF]
Liu A +4 more
europepmc +1 more source
TNF-α blockade for carbamazepine-induced drug reaction with eosinophilia and systemic symptoms. [PDF]
Zou M +7 more
europepmc +1 more source
A Systematic Review of Literature: TNF-α Blockers and JAK Inhibitors for the Treatment of Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Severe Forms of Erythema Multiforme. [PDF]
Salehi S +6 more
europepmc +1 more source
Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review. [PDF]
Pang M, Li L, Zhang Q, Zhao M.
europepmc +1 more source
Persistence, switching, and discontinuation patterns of b/tsDMARDs in patients with rheumatoid arthritis: a single-center retrospective cohort study from Saudi Arabia. [PDF]
Aldosari SA +4 more
europepmc +1 more source
Retroperitoneal Fibrosis following Etanercept for Ankylosing Spondylitis. [PDF]
Goh SL +12 more
europepmc +1 more source
PD-1<sup>hi</sup>CXCR5<sup>-</sup>CD4<sup>+</sup>T Peripheral Helper Cells Were Enriched and Potentially Predicted Clinical Response to Etanercept Therapy in Rheumatoid Arthritis. [PDF]
Xu H +10 more
europepmc +1 more source
Ex vivo JAK and TNF inhibitor-modulated immune signatures guide first-line therapy selection in rheumatoid arthritis. [PDF]
Corrales S +21 more
europepmc +1 more source
Prescription Pattern and Safety of Biologics in Autoimmune Rheumatologic Diseases in Tertiary Care Hospital of Bihar. [PDF]
Shakur AA +4 more
europepmc +1 more source

